Andrew Perry, Chief Commercial Officer at G1 Therapeutics, Inc. (GTHX), sold 820 shares at $5.58 ($5K) on 2023-01-04, disclosed to the SEC on 2023-01-05.
Open-market sale of $5k GTHX by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| GTHX | SELL | 2024-01-08 | $8K | — | Filing → |
| GTHX | SELL | 2023-07-07 | $870 | — | Filing → |